Research News for 2012
-
T-DM1 Improves Survival in Women with HER2-Positive Metastatic Breast Cancer
Women diagnosed with HER2-positive metastatic breast cancer lived longer when they got the experimental medicine T-DM1 compared to women who got a different targeted therapy regimen.
-
New Tool May Help Figure Out Which Older Women Can Skip Radiation After Lumpectomy
To help doctors better understand which older women can safely skip radiation therapy after lumpectomy, researchers have developed a new predictive tool.
-
Survey Says Women Want to See Reconstruction Results Before Breast Cancer Surgery
Survey results reveal that 89% of U.S. women diagnosed with breast cancer want to see what reconstruction results would look like before starting treatment.
-
Exercise Improves Quality of Life During and After Treatment
Two new, separate review studies found that 12 weeks of exercise was linked to better overall quality of life for people being treated for cancer as well as survivors.
-
Xgeva Better Than Zometa at Reducing Risk of Bone Problems in Women with Metastatic Disease
Research suggests that Xgeva is better than Zometa at reducing the risk of bone complication and improves quality of life more in women diagnosed with metastatic breast cancer that has spread to the bones.
-
Chemo During Pregnancy Appears Safe for Mother and Child
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Docs Need to Consider Quality of Life When Assessing Lymphedema
A study strongly suggests that considering a person's quality of life as well as reducing swelling is very important to managing lymphedema.
-
Most Older Women Seem to Benefit from Radiation After Lumpectomy
Contrary to current treatment guidelines, a new study suggests that radiation therapy after lumpectomy may help most older women diagnosed with early-stage, hormone-receptor-positive breast cancer avoid a later mastectomy.
-
Research Suggests How Metastatic Cancer Becomes Resistant to Chemotherapy
A very early study on cancer cells in petri dishes in the lab has found that a type of cell called a fibroblast also is damaged by chemotherapy. Damaged fibroblasts make a protein called WNT16B that may help metastatic cancer cells become resistant to chemotherapy and grow.
-
Injectable Herceptin Shows Promise
A study suggests that an injectable form of Herceptin works just as well as and is as safe as the standard IV form of Herceptin to treat HER2-positive, early-stage breast cancer before surgery.
